Current and future prospects for gene therapy for rare genetic diseases affecting the brain and spinal cord TL Jensen, CR Gøtzsche, DPD Woldbye Frontiers in molecular neuroscience 14, 695937, 2021 | 52 | 2021 |
The Body weight Reducing Effects of Tirzepatide in People with and without Type 2 Diabetes: A Review on Efficacy and Adverse Effects TL Jensen, A Brønden, K Karstoft, DP Sonne, MB Christensen Patient preference and adherence, 373-382, 2024 | 1 | 2024 |
Repeated poisonings in Denmark–a nationwide study TL Jensen, M Tejlbo Frost, K Dalhoff, T Studsgaard Petersen Clinical Toxicology 61 (5), 392-399, 2023 | 1 | 2023 |
Simulationstræning i akut pædiatri AM Andersen, TL Jensen, JL Sørensen, LK Gjærde, S Lund, L Paulsen, ... Ugeskrift for Læger 185 (12), 1156-1160, 2023 | | 2023 |
Tirzepatide for the treatment of type 2 diabetes and obesity TL Jensen, A Bronden, K Karstoft, DP Sonne, MB Christensen DRUGS OF THE FUTURE 48 (3), 179-196, 2023 | | 2023 |
Tirzepatide. Dual GLP-1/GIP receptor agonist, Treatment of type 2 diabetes and obesity TL Jensen, A Bronden, K Karstoft, DP Sonne, MB Christensen Drugs of the Future 2023, 48(3): 179-196, 2023 | | 2023 |